microRNA 4636 (MIR4636)

microRNA 4636 (MIR4636) is a small, non-coding RNA molecule belonging to the microRNA family. MicroRNAs such as MIR4636 function by binding to complementary sequences on target messenger RNAs, typically resulting in their silencing through translation repression or target degradation. There is no evidence that MIR4636 is a common focus of drug development, nor that it has established roles as a biomarker, disease driver, or therapeutic target in major disease categories. The existence of commercial synthetic inhibitors (e.g., hsa-miR-4636 inhibitor) reflects its molecular identity rather than any established therapeutic relevance[3]. There are currently no clinical drugs known to modulate MIR4636 or its activity, and the molecule is not cited as a receptor, enzyme, or established therapeutic target in cancer, inflammation, neurodegeneration, or other diseases[1][2][3][4].

Other names

hsa-mir-4636mir-4636hsa-miR-4636MIR4636